Sectoral Asset Management’s Vera Therapeutics VERA Stock Holding History

Sectoral Asset Management’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Hold	25,573	–	–	0.77%	42
2026 Q1	$1.08M	Sell	25,573 -11,285	-31%	-$486K	0.9%	28
2025 Q4	$1.87M	Buy	36,858 +6,670	+22%	+$237K	1.5%	22
2025 Q3	$877K	Sell	30,188 -11,230	-27%	-$260K	0.54%	54
2025 Q2	$976K	Buy	41,418 +13,070	+46%	+$294K	0.64%	48
2025 Q1	$681K	Buy	28,348 +22,648	+397%	+$728K	0.53%	46
2024 Q4	$241K	Sell	5,700 -1,728	-23%	-$76.5K	0.16%	69
2024 Q3	$328K	Sell	7,428 -290	-4%	-$11K	0.19%	72
2024 Q2	$279K	Sell	7,718 -37,183	-83%	-$1.47M	0.11%	81
2024 Q1	$1.94M	Sell	44,901 -79,250	-64%	-$2.82M	0.76%	40
2023 Q4	$1.91M	Sell	124,151 -232,988	-65%	-$2.96M	0.82%	48
2023 Q3	$4.9M	Buy	357,139 +5,493	+2%	+$94.2K	0.95%	45
2023 Q2	$5.64M	Sell	351,646 -248,654	-41%	-$2.25M	0.94%	46
2023 Q1	$4.66M	Buy	+600,300	New	+$4.63M	0.9%	50

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sectoral Asset Management's VERA Position: Q2 2026 in Review

Sectoral Asset Management held its Vera Therapeutics (VERA) position steady in Q2 2026 at 25,573 shares worth $1.1M. The position accounts for 0.77% of the portfolio, ranked #42.

Sectoral Asset Management first reported a position in VERA in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.64M in Q2 2023. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Sectoral Asset Management held 25,573 shares of Vera Therapeutics worth $1.1M as of Q2 2026.
Sectoral Asset Management left its Vera Therapeutics share count unchanged in Q2 2026.
Vera Therapeutics made up 0.77% of Sectoral Asset Management's portfolio in Q2 2026, its #42 holding.
Sectoral Asset Management first reported a position in Vera Therapeutics in Q1 2023 and has held it in 14 quarters since.
Sectoral Asset Management's Vera Therapeutics position peaked at $5.64M in Q2 2023.
219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.